Optimisation of Cardiac Resynchronisation Therapy by Non-invasive Cardiac Output - The CHOICE2 Study

An evaluation of the role of resting and exercise cardiac output measurement, by the inert gas rebreathing method, in optimisation of patients with cardiac resynchronisation pacemakers.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Heart Failure Cardiac Resynchronisation Pacemakers Cardiovascular Diseases Heart Diseases

Age range

18 year–100 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of Dundee

Dundee, United Kingdom

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Cardiac Resynchronization Device in situ for Heart Failure

Exclusion criteria

Unable to cope with mouthpiece
Estimated life expectancy < 6 months

Treatment and study plan

Optimisation of VV delay

Device

Programmed VV delay altered on device

Primary outcomes

6 minute hall walk test

Time frame: 4 months

Secondary outcomes

Echocardiographic measures of desynchrony

Time frame: 3 months

Sponsors and collaborators

Lead sponsor

University of Dundee

Other

Registry information

Acronym: CHOICE2

Important dates

Study start: 2010
Primary completion: 2013
Study completion: 2013
First posted: Jan 25, 2010
Registry last updated: Dec 3, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed